Anupam Agarwal

Anupam Agarwal is a physician-executive working in drug safety and artificial intelligence in medicine, with about two decades of experience in the pharmaceutical and biotechnology industry. Trained in cardiology and board-certified in internal medicine, he holds a Master of Public Health in clinical research from Harvard. He was Senior Vice President and Global Head of Safety and Pharmacovigilance at Denovo Biopharma, and earlier held drug safety roles at GSK, Pfizer, Gilead, and Zogenix. At Zogenix, he built the cardiovascular safety monitoring program that allowed fenfluramine to be approved without a Food and Drug Administration advisory committee meeting. He is the Immediate Past President of the Harvard Club of San Francisco and an active angel investor.

Popular items by Anupam Agarwal

View all offers